微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 5.49% | 10.91% | 111.97% | 13/51 | 3.32% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | 2.59% | -27.86% | 292.42% | 21/51 | 2.09% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | 0.66% | -66.5% | -85.37% | 29/51 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | 4.51% | -43.63% | -8.89% | 25/51 | 3.73% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | 4.95% | -39.56% | 37.88% | 26/51 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | 3.59% | -38.21% | 82.23% | 23/51 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | 1.97% | -41.54% | -75.38% | 22/51 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | 8% | -47.05% | -2.32% | 25/51 | -0.62% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | 8.19% | -55.46% | 40.96% | 24/51 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | 5.81% | -64.4% | 72.4% | 19/51 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
| 2022-03-31 | 3.37% | -65.08% | -77.7% | 17/51 | 3.14% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-12-31 | 15.11% | -40.88% | -17.84% | 17/51 | -6.68% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-09-30 | 18.39% | 1432.61% | 12.68% | 7/51 | 2.3% | 金域医学 | 43.58% | 行业排名> |
| 2021-06-30 | 16.32% | 59.38% | 69.12% | 4/51 | 2.28% | 金域医学 | 35.41% | 行业排名> |
| 2021-03-31 | 9.65% | 2% | -62.25% | 4/51 | 1.79% | 阳光诺和 | 26.2% | 行业排名> |
| 2020-12-31 | 25.56% | 28.83% | 149.61% | 9/51 | 10.95% | 金域医学 | 13.23% | 行业排名> |
| 2020-06-30 | 10.24% | -50.86% | -48.39% | 7/51 | 2.48% | 万邦医药 | 52.05% | 行业排名> |
| 2019-12-31 | 19.84% | -30.58% | -30.58% | 14/51 | 65.31% | 华大基因 | 48.52% | 行业排名> |
| 2018-12-31 | 28.58% | 44.2% | 44.2% | 6/51 | -0.6% | 华大基因 | 31.24% | 行业排名> |
| 2017-12-31 | 19.82% | -43.29% | -4.89% | 6/51 | 1.73% | 阳光诺和 | 13.99% | 行业排名> |
| 2017-06-30 | 20.84% | 43.03% | -40.37% | 3/51 | 60.47% | 南华生物 | 2848.07% | 行业排名> |
| 2016-12-31 | 34.95% | 203.39% | 139.88% | 2/51 | 23.06% | 南华生物 | 98.98% | 行业排名> |
| 2016-06-30 | 14.57% | 2% | 26.48% | 3/51 | 4.57% | 南华生物 | 82.46% | 行业排名> |
| 2015-12-31 | 11.52% | 274.28% | 934.78% | 14/51 | 22.23% | 南华生物 | 48.41% | 行业排名> |
| 2015-09-30 | -1.38% | 2% | 79.12% | 17/51 | 5.27% | 万邦医药 | 106.72% | 行业排名> |